Case File
efta-efta01761835DOJ Data Set 10CorrespondenceEFTA Document EFTA01761835
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01761835
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Farkas, Andrew L. <
Sent:
Thursday, April 18, 2013 6:34 PM
To:
[email protected]'
Subject:
Re:
The investor presentation was a solid 10. But the performance has been exemplary. 52% average asset value
appreciation if the fund since inception 18 mos ago. We announced the launch of fund ii this am an it was 66%
subscribed right there on the spot.
Tom is in st thomas. I have not heard anything further on that yet.
Very sad.
Everyone at home hasMi I'm walking into Dan Och's office.
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Thursday, April 18, 2013 01:30 PM
To: Farkas, Andrew L
Subject:
did it go ok
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This message, and any attachments hereto, is confidential and intended exclusively for the use of the individual or entity
to whom it is addressed. This communication may contain information that is confidential, proprietary, privileged,
subject to a confidentiality and/or non-disclosure agreement, or otherwise exempt or protected from disclosure (either
by contract or under applicable law). If you are not the intended recipient, you are hereby notified that printing,
EFTA_R1_00066867
EFTA01761835
retaining, reproducing, copying, disclosing, disseminating or using this message or any information contained herein
(including any reliance thereon) is strictly prohibited. If you have received this message in error, please contact the
sender immediately and destroy the message (including any attachments) and any copies in their entirety, whether in
electronic or hard copy format. Nothing contained in this e-mail shall be considered a legally binding agreement,
amendment or modification of any agreement with Island Capital Group LLC or any of its affiliates, each of which
requires a fully executed agreement to be received by Island Capital Group LLC or such affiliate.
2
EFTA_R1_00066868
EFTA01761836
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.